The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...

HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...

Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections.

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...